Rights and permissions
About this article
Cite this article
IFN-β cost effective for MS after all?. Inpharma Wkly. 1247, 7 (2000). https://doi.org/10.2165/00128413-200012470-00014
Published:
Issue Date:
DOI: https://doi.org/10.2165/00128413-200012470-00014